Basem M. William

4.4k total citations
96 papers, 1.4k citations indexed

About

Basem M. William is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Basem M. William has authored 96 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pathology and Forensic Medicine, 37 papers in Oncology and 28 papers in Hematology. Recurrent topics in Basem M. William's work include Lymphoma Diagnosis and Treatment (46 papers), CAR-T cell therapy research (25 papers) and Chronic Lymphocytic Leukemia Research (22 papers). Basem M. William is often cited by papers focused on Lymphoma Diagnosis and Treatment (46 papers), CAR-T cell therapy research (25 papers) and Chronic Lymphocytic Leukemia Research (22 papers). Basem M. William collaborates with scholars based in United States, United Kingdom and France. Basem M. William's co-authors include Gino Roberto Corazza, Jamés O. Armitage, Sutthichai Sae-Tia, Shuming Yang, Paolo F. Caimi, Pierluigi Porcu, Marcos de Lima, Yan Xu, Philip J. Bierman and Betül Oran and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Basem M. William

90 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Basem M. William United States 20 457 395 329 316 268 96 1.4k
T. Nousiainen Finland 26 650 1.4× 383 1.0× 269 0.8× 607 1.9× 174 0.6× 48 1.7k
Jin Ho Baek South Korea 21 626 1.4× 136 0.3× 266 0.8× 383 1.2× 222 0.8× 100 1.4k
Milan J. Anadkat United States 22 733 1.6× 231 0.6× 276 0.8× 94 0.3× 399 1.5× 68 1.8k
R. Arranz Spain 21 861 1.9× 717 1.8× 119 0.4× 429 1.4× 340 1.3× 42 1.5k
Leona Holmberg United States 21 457 1.0× 229 0.6× 290 0.9× 566 1.8× 323 1.2× 44 1.5k
Dong‐Yeop Shin South Korea 18 534 1.2× 244 0.6× 269 0.8× 323 1.0× 139 0.5× 147 1.3k
Frank S. Fan Taiwan 20 358 0.8× 198 0.5× 256 0.8× 217 0.7× 83 0.3× 84 1.4k
Driss Chaoui France 16 478 1.0× 161 0.4× 318 1.0× 324 1.0× 54 0.2× 29 1.1k
Leona Holmberg United States 24 809 1.8× 442 1.1× 654 2.0× 1.0k 3.3× 411 1.5× 99 2.2k
Hawk Kim South Korea 22 443 1.0× 256 0.6× 342 1.0× 882 2.8× 226 0.8× 111 1.5k

Countries citing papers authored by Basem M. William

Since Specialization
Citations

This map shows the geographic impact of Basem M. William's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Basem M. William with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Basem M. William more than expected).

Fields of papers citing papers by Basem M. William

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Basem M. William. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Basem M. William. The network helps show where Basem M. William may publish in the future.

Co-authorship network of co-authors of Basem M. William

This figure shows the co-authorship network connecting the top 25 collaborators of Basem M. William. A scholar is included among the top collaborators of Basem M. William based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Basem M. William. Basem M. William is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Reneau, John, et al.. (2024). Final Results of a Phase II Study of Brentuximab Vedotin and Lenalidomide in Relapsed and Refractory T-Cell Lymphomas. Blood. 144(Supplement 1). 4438–4438. 1 indexed citations
3.
Woost, Philip G., Basem M. William, Brenda Cooper, et al.. (2024). Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies. Cytometry Part B Clinical Cytometry. 106(1). 11–24.
4.
Jiang, Justin, Audrey M. Sigmund, Qiuhong Zhao, et al.. (2024). Impact of chronic graft- versus -host disease on non-relapse mortality and survival. Leukemia & lymphoma. 65(11). 1698–1705. 1 indexed citations
5.
Maakaron, Joseph & Basem M. William. (2023). Age is No Barrier: CAR-T Therapy in Older Adults. Drugs & Aging. 40(8). 685–689. 1 indexed citations
6.
Schaefer, Andrew, Ying Huang, Adam S. Kittai, et al.. (2021). Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience. Cancer Management and Research. Volume 13. 8901–8906. 17 indexed citations
7.
Zhao, Qiuhong, Patrick Elder, Jonathan E. Brammer, et al.. (2020). Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS. Leukemia & lymphoma. 62(4). 944–951. 5 indexed citations
8.
Maakaron, Joseph, Zeinab El Boghdadly, Ying Huang, et al.. (2020). Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look. Biology of Blood and Marrow Transplantation. 26(8). e198–e201. 13 indexed citations
9.
Vu, Khoan, Chen‐Yen Yang, Laura B. Pincus, et al.. (2019). Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study. Clinical Cancer Research. 26(5). 1000–1008. 33 indexed citations
10.
Poh, Christina, Paul Frankel, Christopher Ruel, et al.. (2019). Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin's Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative Analysis. Blood. 134(Supplement_1). 760–760. 25 indexed citations
11.
Chung, Catherine, et al.. (2019). Dramatic and Durable Responses to Romidepsin in Two Patients With the Lymphocytic Variant of Hypereosinophilic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 20(3). e128–e130. 3 indexed citations
12.
Kohnken, Rebecca, Jing Wen, Kathleen McConnell, et al.. (2019). Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology. 139(9). 1966–1974.e3. 26 indexed citations
13.
Tomlinson, Benjamin, Molly Gallogly, Leland Metheny, et al.. (2019). A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia. Clinical Lymphoma Myeloma & Leukemia. 20(4). 226–233.e1. 19 indexed citations
14.
Denlinger, Nathan, Narendranath Epperla, & Basem M. William. (2018). Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib. Cancer Management and Research. Volume 10. 615–624. 19 indexed citations
15.
Ueda, Masumi, Brenda Cooper, Paolo F. Caimi, et al.. (2018). Low-Dose Azacitidine with DNMT1 Level Monitoring to Treat Post-Transplantation Acute Myelogenous Leukemia or Myelodysplastic Syndrome Relapse. Biology of Blood and Marrow Transplantation. 25(6). 1122–1127. 9 indexed citations
16.
Eulitt, Patrick, et al.. (2017). Waldenström’s macroglobulinemia masquerading as ovarian cancer with peritoneal carcinomatosis, ascites, and elevated CA-125. Hematology/Oncology and Stem Cell Therapy. 12(1). 54–59.
17.
18.
Caimi, Paolo F., Basem M. William, Pingfu Fu, et al.. (2015). Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients. Biology of Blood and Marrow Transplantation. 21(11). 1926–1931. 3 indexed citations
19.
William, Basem M., Fausto R. Loberiza, Philip J. Bierman, et al.. (2013). Impact of Conditioning Regimen on Outcome of 2-Year Disease-Free Survivors of Autologous Stem Cell Transplantation for Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 13(4). 417–423. 19 indexed citations
20.
William, Basem M., et al.. (2011). Small lymphocytic lymphoma in a patient with CREST syndrome. Hematology/Oncology and Stem Cell Therapy. 4(3). 132–135. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Nousiainen Breakdown of academic impact, for papers by Jin Ho Baek Breakdown of academic impact, for papers by Milan J. Anadkat Breakdown of academic impact, for papers by R. Arranz Breakdown of academic impact, for papers by Leona Holmberg Breakdown of academic impact, for papers by Dong‐Yeop Shin Breakdown of academic impact, for papers by Frank S. Fan Breakdown of academic impact, for papers by Driss Chaoui Breakdown of academic impact, for papers by Leona Holmberg Breakdown of academic impact, for papers by Hawk Kim
Rankless by CCL
2026